Variant report
Variant | nsv1037041 |
---|---|
Chromosome Location | chr12:11477123-11504091 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4763681 | chr12:11477123-11477124 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs202072322 | chr12:11477137-11477138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113378839 | chr12:11477141-11477142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555190149 | chr12:11477148-11477149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186285254 | chr12:11477149-11477150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543964789 | chr12:11477153-11477154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79224910 | chr12:11477159-11477160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564031837 | chr12:11477186-11477187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12099553 | chr12:11477187-11477188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571970656 | chr12:11477279-11477280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117871579 | chr12:11477307-11477308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189635951 | chr12:11477342-11477343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117273764 | chr12:11477360-11477361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528838808 | chr12:11477401-11477402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540677193 | chr12:11477409-11477410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568729980 | chr12:11477442-11477443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560188974 | chr12:11477457-11477458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531131602 | chr12:11477495-11477496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183415157 | chr12:11477500-11477501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6488392 | chr12:11477514-11477515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs6488393 | chr12:11477535-11477536 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
22 | rs553121790 | chr12:11477541-11477542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144613677 | chr12:11477555-11477556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535401180 | chr12:11477565-11477566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555253759 | chr12:11477579-11477580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76060689 | chr12:11477597-11477598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186341357 | chr12:11477606-11477607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147879699 | chr12:11477612-11477613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548877453 | chr12:11477616-11477617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190783775 | chr12:11477650-11477651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540318122 | chr12:11477657-11477658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559929974 | chr12:11477689-11477690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371760893 | chr12:11477696-11477697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573686723 | chr12:11477712-11477713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542598046 | chr12:11477731-11477732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562389666 | chr12:11477763-11477764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531195261 | chr12:11477791-11477792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554025664 | chr12:11477792-11477793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550926641 | chr12:11477819-11477820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141615183 | chr12:11477830-11477831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568619051 | chr12:11477870-11477871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533312150 | chr12:11477879-11477880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs59523126 | chr12:11477887-11477888 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs566587772 | chr12:11477911-11477912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553923639 | chr12:11477971-11477972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535461599 | chr12:11478009-11478010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150435860 | chr12:11478018-11478019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372257069 | chr12:11478030-11478031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs367717691 | chr12:11478031-11478032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568829488 | chr12:11478059-11478060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:11475400-11478200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr12:11478200-11479200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr12:11478800-11479400 | Enhancers | HMEC | breast |
4 | chr12:11479000-11479200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr12:11479200-11480200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr12:11479200-11493000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr12:11486800-11487000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr12:11493000-11493200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr12:11493000-11493400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr12:11493000-11494200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr12:11494200-11496400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr12:11496600-11496800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr12:11496800-11499400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr12:11497200-11497800 | Enhancers | HepG2 | liver |
15 | chr12:11497800-11498600 | Enhancers | Fetal Intestine Small | intestine |
16 | chr12:11498200-11498600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr12:11504000-11505000 | Enhancers | HUVEC | blood vessel |